James Murrough

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, James Murrough sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).

9 total trials none currently recruiting 8 completed early-phase tilt top decile by trial count

James Murrough: 9 sponsored US clinical trials, none currently recruiting.

James Murrough sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 8 completed. 1 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Major Depressive Disorder, with 1 trials.

Top-decile sponsor footprint

James Murrough ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Indexed trials (enrollment closed)

9 total, page 1 of 1

COMPLETED Phase 1

Study of Harmine in Healthy Subjects

NCT05526430
COMPLETED Phase 2

XEN1101 for Major Depressive Disorder

NCT04827901
COMPLETED Phase 2

Study to Treat Major Depressive Disorder With a New Medication

NCT03043560
COMPLETED Phase 2

Nuedexta in Treatment-Resistant Major Depression

NCT01882829
COMPLETED Phase 1

A Dose Escalation Study of Intranasal Neuropeptide Y in Post Traumatic Stress Disorder (PTSD)

NCT01533519
COMPLETED Phase 4

Ketamine For Suicidal Ideation

NCT01507181
COMPLETED NA

Intranasal Ketamine in Treatment-Resistant Depression

NCT01304147
TERMINATED NA

Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression

NCT01309581
COMPLETED Phase 1

Continuation Ketamine in Major Depression

NCT00548964

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 3
Phase 4 1

Therapeutic Areas

Major Depressive Disorder 1

How the James Murrough early-phase archive is shaped

9 indexed studies, none listed as recruiting (0% open); 8 completed (89%).

Phase mix: 1 late (III/IV) vs 6 early (I/II) (early-phase heavy).

Top condition: Major Depressive Disorder (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

James Murrough: archived-pipeline peers nationwide

Peers matched on 9 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

James Murrough sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40%50% Total trials Recruiting share James Murrough4D Molecular Therapeutics9 Meters BiopharmaAadi BioscienceAblynx, a Sanofi company10xBio22nd Century Group23andMe3-C Institute for Social Development
James Murrough sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

James Murrough sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 9 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this James Murrough page

9 registered trials is a research-attention snapshot, not an endorsement of James Murrough or any single study.

  • None of James Murrough's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Major Depressive Disorder is the condition James Murrough studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Major Depressive Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. James Murrough pipeline card: 9 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.